Menu

Team

Scientific Leadership

Mathieu Vandenbulcke

Director at KU Leuven Brain Institute

Geriatric psychiatrist at UZ Leuven and UPC KU Leuven

Head of the research group Neuropsychiatry at KU Leuven

Chair of the Scientific Committee at Mission Lucidity



Bart De Strooper

Group leader at the VIB-KU Leuven Center for Brain & Disease Research

Director of the UK DRI

Scientific lead at Mission Lucidity

Coordinator of the TRIAGE project



Rik Vandenberghe

Head of the memory clinic at UZ Leuven

Head of the Laboratory for Cognitive Neurology at KU Leuven

Clinical lead at Mission Lucidity



Dries Braeken

R&D Manager Life Science Technologies at imec

Technology lead at Mission Lucidity

Coordinator of the brain organoid project



Patrik Verstreken

Ingeborg Stalmans

Head of the Research Group Ophthalmology at KU Leuven

Ophthalmologist at UZ Leuven

Coordinator of the ADMIRE project



Peter Janssen

Head of the laboratory for Neuro- and psychophysiology at KU Leuven

Coordinator of the TESCOGEN project



Sebastian Haesler

Management Team

Jenny Ceccarini

Program development officer at Mission Lucidity

Chair of the management and fundraising teams

 

Contact

jenny.ceccarini@kuleuven.be

Tel. +32 16 32 89 60



An Schreurs

Head of communications at Mission Lucidity

Science journalist at UZ Leuven

 

Contact

an.schreurs@kuleuven.be

Tel. +32 16 34 49 39



Steering Committee

Urbain Vandeurzen

Chairman Smile Invest, Honorary Chairman VOKA, Flanders’ Chamber of Commerce and Industry and Chairman of the Campaign Board Opening the Future - KU Leuven

"Neurodegenerative diseases affect numerous people worldwide but despite intensive research, effective treatments are still lacking. As a serial entrepreneur, it is my experience that when world-class researchers that are driven by a compelling vision and ambition, get access to sufficient resources and breakthrough technology, they can achieve what seemingly looked impossible. That is why with Mission Lucidity, we want to create the conditions to fundamentally decode dementia."

Luc Van den hove

President & CEO imec

“I strongly believe that there is hope for dementia. Thanks to the advances in nanotechnology we can now measure what hasn’t been measured before. We can now develop groundbreaking tools, that allow us gain a profoundly deeper understanding in the disease than ever before. With Mission Lucidity, we have all the expertise from world-renown partners in hand – biomedical, clinical and nanotechnological - to bring hope for dementia.”

Koenraad Debackere

Managing Director KU Leuven

“What makes humans unique? Everyone investigating that question cannot ignore the human brain, the way it developed and functions. We understand what others think given our knowledge of the world. We understand what others cannot know. That lucidity defines us. Unfortunately, it can also fail us. That is why we must decode dementia. To safeguard or give back the lucidity that uniquely defines us.”

Wim Robberecht

Chief Executive Officer UZ Leuven

“In the next decades, we will be confronted with a tsunami of chronic illnesses due to aging of the population. Mental disorders are responsible for the largest portion of these chronic diseases, with dementia posing the greatest challenge. That is why it must be decoded, to give people back what is their most human characteristic: their lucidity.”

Jérôme Van Biervliet

Managing Director VIB

“Although our understanding of dementia has increased tremendously in the last two decades and despite all the efforts to find new drugs, there is still no cure. The right way forward is a cross-disciplinary initiative that combines the expertise of basic science with disruptive technologies and accelerates translation to patients.”

Other members

Other members of Mission Lucidity's Steering Committee include Jo De Boeck (Chief Strategy Officer at imec), Chris Van Geet (vice rector at KU Leuven), Gert Van Assche (Chief Medical Officer at UZ Leuven) and Wim Goemaere (Chief Operating Officer at VIB)